T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Lyell Immunopharma
LYEL
$337M
| $214K | ﹤0.01% |
13,128
-292,931
| -96% | -$3.35M |
|
2752
Marcus Corp
MCS
$929M
| $214K | ﹤0.01% |
13,771
+1,199
| +10% | +$19.2K |
|
|
SEMR
2753
DELISTED
Semrush
SEMR
| $214K | ﹤0.01% |
30,127
+7,105
| +31% | +$57.9K |
|
2754
KVH Industries
KVHI
$143M
| $212K | ﹤0.01% |
37,763
| – | – |
|
|
LOVE
2755
LoveSac
LOVE
$258M
| $212K | ﹤0.01% |
12,520
+373
| +3% | +$6.93K |
|
2756
Kelly Services Class A
KELYA
$566M
| $211K | ﹤0.01% |
16,073
+979
| +6% | +$13.1K |
|
2757
Outset Medical
OM
$79.9M
| $210K | ﹤0.01% |
14,827
+3,400
| +30% | +$53K |
|
2758
Sanara MedTech
SMTI
$314M
| $210K | ﹤0.01% |
+6,598
| New | +$199K |
|
2759
Dakota Gold
DC
$827M
| $209K | ﹤0.01% |
45,903
+2,780
| +6% | +$11.7K |
|
2760
Civista Bancshares
CIVB
$595M
| $208K | ﹤0.01% |
+10,196
| New | +$214K |
|
2761
International Money Express
IMXI
$353M
| $208K | ﹤0.01% |
14,866
+1,080
| +8% | +$13.4K |
|
2762
Weave Communications
WEAV
$426M
| $208K | ﹤0.01% |
31,005
+1,827
| +6% | +$14.1K |
|
|
MAGN
2763
Magnera Corp
MAGN
$433M
| $208K | ﹤0.01% |
17,701
+1,040
| +6% | +$12.9K |
|
2764
GoPro
GPRO
$117M
| $206K | ﹤0.01% |
96,763
-128,800
| -57% | -$191K |
|
2765
NRC Health Common Stock
NRC
$471M
| $206K | ﹤0.01% |
16,066
| – | – |
|
2766
Custom Truck One Source
CTOS
$2.33B
| $205K | ﹤0.01% |
31,797
+1,586
| +5% | +$9.19K |
|
2767
Erasca
ERAS
$6.25B
| $205K | ﹤0.01% |
93,580
+7,112
| +8% | +$11.3K |
|
2768
Standard BioTools
LAB
$294M
| $205K | ﹤0.01% |
157,542
-52,119
| -25% | -$68.3K |
|
|
BKV
2769
BKV Corp
BKV
$2.84B
| $205K | ﹤0.01% |
8,847
+458
| +5% | +$9.98K |
|
2770
America Movil
AMX
$69.8B
| $204K | ﹤0.01% |
+9,700
| New | +$185K |
|
|
DHIL
2771
DELISTED
Diamond Hill
DHIL
| $204K | ﹤0.01% |
+1,453
| New | +$212K |
|
|
ITIC
2772
Investors Title Co
ITIC
$534M
| $202K | ﹤0.01% |
+754
| New | +$175K |
|
2773
Southern California Bancorp
BCAL
$699M
| $201K | ﹤0.01% |
12,010
+609
| +5% | +$10K |
|
2774
Bakkt Inc
BKKT
$331M
| $201K | ﹤0.01% |
+5,965
| New | +$82.1K |
|
2775
Superior Group of Companies
SGC
$210M
| $201K | ﹤0.01% |
18,710
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.